These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4814198)

  • 1. Circadian rhythm in survivorship after removal of Ehrlich ascites tumor.
    Brown HR
    Transplantation; 1974 Mar; 17(3):322-3. PubMed ID: 4814198
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian influence on the immunization of mice with live Bacillus Calmette-Guérin (BCG) and subsequent challenge with Ehrlich ascites carcinoma.
    Tsai TH; Burns RE; Scheving LE
    Chronobiologia; 1979; 6(3):187-201. PubMed ID: 520096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).
    Yarkoni E; Bekierkunst A; Asselineau J; Toubiana R; Toubiana MJ; Lederer E
    J Natl Cancer Inst; 1973 Aug; 51(2):717-20. PubMed ID: 4765386
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors influencing skin graft survival from donors with Ehrlich ascites tumor.
    Biran S; Ben-Hur N; Robinson E
    Oncology; 1970; 24(5):344-8. PubMed ID: 4922595
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F; Halleraker B
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell proliferation during the course of immunological rejection of Ehrlich ascites tumour cells.
    Janik P
    Cell Tissue Kinet; 1971 Jan; 4(1):69-74. PubMed ID: 5116589
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
    Belokhvostov AS; Zelenkova NK
    Biull Eksp Biol Med; 1978 Oct; 86(10):474-6. PubMed ID: 361103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The survival time of irradiated mice with Ehrlich's ascites carcinoma.
    Thunold S
    Acta Pathol Microbiol Scand; 1966; 68(1):47-53. PubMed ID: 5954973
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P; Dabrowski M; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance and susceptibility to tumours. IV. The temporary survival and rejection of the Ehrlich ascites carcinoma in xenogeneic hosts.
    Dvorák R; Karásek J
    Neoplasma; 1970; 17(4):361-71. PubMed ID: 4394171
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
    Yasuhira K
    Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimentally acquired resistance to tumor transplantation and the rejection of homologous skin transplantation in mice].
    Enoki Y
    Igaku To Seibutsugaku; 1967 Mar; 74(3):185-6. PubMed ID: 4861830
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor(s) from Ehrlich Ascites cells responsible for delayed rejection of skin allografts in mice and its assay on lymphocytes in vitro.
    Gresser I; Vignaux F; Maury C; Lindahl P
    Proc Soc Exp Biol Med; 1975 May; 149(1):83-8. PubMed ID: 1096161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
    Sethi KK; Brandis H
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of altered lighting regimens, time-limited feeding, and presence of Ehrlich ascites carcinoma on the circadian rhythm in DNA synthesis of mouse spleen.
    Burns ER; Scheving LE; Pauly JE; Tsai T
    Cancer Res; 1976 May; 36(5):1538-44. PubMed ID: 1268817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
    Loring M; Schlesinger M
    Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumour effect of different corynebacterial immunostimulants in non isogenic mouse-tumour-system. (Short communication).
    Géresi M; Réthy L; Ecsy R; Gelencsér F; Padányi M; Pogány I; Bácskai L; Réthy LA
    Acta Vet Acad Sci Hung; 1981; 28(3):281-3. PubMed ID: 7258017
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of purine-protein conjugates on the Ehrlich ascites tumor in mice.
    Lachman C; Cohen S
    Cancer Res; 1970 Feb; 30(2):439-46. PubMed ID: 5441091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.